Sildenafil
Product Images NDC 53002-3719

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 53002-3719). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Camber1 (Camber1)

Camber1 (Camber1)
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
This text provides information on interacting drugs, including Atorvastatin, Azithromycin, Bosentan, Cimetidine, Erythromycin, and Maalox. It also mentions oral contraceptives and Ritonavir. The text includes parameters such as AuC and Cmax, as well as fold changes and 90% CI values. The recommendation provided is mainly "No dose adjustment," except for Bosentan where dose adjustment is not recommended.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
FDA Label Image

Figure-6 (Figure 6)

Figure-6 (Figure 6)
FDA Label Image

Label Image (Lbl530023719)

Label Image (Lbl530023719)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.